Sheldon Sloan, Chief Medical Officer: Spyre Therapeutics SYRE Sell · Filed 04/03

Trade details

Type: Insider sale
Amount: $397,900
Shares · price: 7,958 sh · $50.00 a share
Held after: 0 sh
Stock: Spyre Therapeutics SYRE
Person: Sheldon SloanChief Medical Officer
Trade date: 26/04/01
Filed: 26/04/03
Days to filing: 2 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 03/02~05/01

Sheldon Sloan's recent trades

Sheldon SloanChief Medical Officer
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$625K
8,333 sh
$625K
Filed 06/03
Traded 06/03
Sheldon SloanChief Medical Officer
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$1.2M
16,667 sh
$1.2M
Filed 06/03
Traded 06/03
Sheldon SloanChief Medical Officer
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$1.5M
21,306 sh
$1.5M
Filed 05/01
Traded 05/01
Sheldon SloanChief Medical Officer
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$1.4M
19,656 sh
$1.4M
Filed 05/01
Traded 05/01
Sheldon SloanChief Medical Officer
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$932K
12,777 sh
$932K
Filed 05/01
Traded 05/01

Sheldon Sloan, Chief Officer — sold $397.9K of Spyre Therapeutics SYRE · 100.0% of holdings · 10b5-1 plan | Whalegun